CERTARA INC (CERT)

Company Profile

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. The company is headquartered in Radnor, Pennsylvania and currently employs 1,338 full-time employees. The company went IPO on 2020-12-11. The firm accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. The company delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. The company also develops scientific informatics software products used by the life sciences industry for in-silico research. The company develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.

Company Info

CERTARA INC

4 Radnor Corporate Center, Suite 350

Radnor PENNSYLVANIA 08540

P: 14152378272

CEO: William F. Feehery

Employees: 1365

Website: https://www.certara.com/